Farther Finance Advisors »

Cartesian Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $289 18 16.11
2024-06-30 $435 18 24.22
2024-03-31 $302 539 0.56

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Microsoft Corp Stock (MSFT)
Uva Unconstrained Medium-term Fixed Income Etf Etf (FFIU)
Ishares National Muni Bond Etf Etf (MUB)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Amazon Stock (AMZN)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares S&p 500 Growth Etf Etf (IVW)

View all positions for Farther Finance Advisors

Top funds holding Cartesian Therapeutics

Siren
BlackRock
BlackRock
Citadel Advisors
Jpmorgan Chase & Co
MPM Oncology Impact Management
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Erste Asset Management GmbH
State Street Corporation
Geode Capital Management
Yale University
Logos Global Management
683 Capital Management
Northern Trust

View all funds holding Cartesian Therapeutics